跳至主要内容
临床试验/NCT06051890
NCT06051890招募中4 期

Assessing Optimal Extended-Release Buprenorphine (XRB) Initiation Points in Jail

NYU Langone Health8 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年6月2日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
招募中
入组人数
50
试验地点
8
主要终点
Percentage of participants released from jail with at least 7 days of buprenorphine in their system

研究概览

简要总结

This application describes a 3-year, randomized controlled trial. Eligible, consenting adults (N=200) with existing sublingual buprenorphine (SLB) prescriptions who enter Middlesex County House of Corrections (MCHOC) as pre-trial detainees will be randomized at admission on a 1:1 basis to be inducted onto extended-release buprenorphine (XRB) at the time of admission (experimental condition) or remain in SLB (E-TAU; all participants will also receive naloxone). The two approaches will be compared with regard to (1) the percentage of participants released from jail with at least 7 days of buprenorphine in their system, (2) percentage of participants continuing MOUD treatment in the community, and (3) infractions related to buprenorphine diversion.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

性别
Male
接受健康志愿者

入选标准

  • Incarcerated men able to provide written informed consent in English.*
  • Unsentenced.
  • Entering the facility with a prescription for SLB and receiving SLB for at least the previous 3 days.
  • Minimum anticipated jail stay is 4 days.
  • Willing to accept being randomized to the experimental condition (i.e., transitioning to XRB while incarcerated).

排除标准

  • Sentenced.
  • Allergy, hypersensitivity or medical contraindication to either medication.
  • Chronic pain requiring opioid pain management or other contraindicated medications.

研究组 & 干预措施

Transition to Extended-Release Buprenorphine (XRB)

Experimental

Participants randomized to transition to treatment with XRB.

干预措施: Extended-Release Buprenorphine (XRB) (Drug)

Sublingual Buprenorphine (SLB) Maintenance

Active Comparator

Participants randomized to remain on-treatment with SLB.

干预措施: Sublingual Buprenorphine (SLB) (Drug)

结局指标

主要结局

Percentage of participants released from jail with at least 7 days of buprenorphine in their system

时间窗: Up to Month 6

The percentage of participants leaving jail with at least 7 days of buprenorphine protection in their system. Measured using clinical and jail records.

次要结局

  • Percentage of participants continuing MOUD treatment in the community(Up to Month 9)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验

Assessing Optimal XRB Initiation Points in Jail | 临床试验